Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Boostrix vs Boostrix-IPV/Td vs Td in Adults
NCT01294605Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2003
- Primary completion
- Sep 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 4 trial of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated), Boostrix Polio in Tetanus, diphtheria, pertussis, poliomyelitis, sponsored by GSK. Started Apr 2003; status: completed.
02
Drugs
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)Boostrix Polio
03
Conditions
Tetanusdiphtheriapertussispoliomyelitis
Beyond the preview
Go deeper on NCT01294605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01294605.